BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22087663)

  • 1. Post-genomics of Neisseria meningitidis: an update.
    Bernardini G; Braconi D; Lusini P; Santucci A
    Expert Rev Proteomics; 2011 Dec; 8(6):803-11. PubMed ID: 22087663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postgenomics of Neisseria meningitidis: an update.
    Bernardini G; Braconi D; Lusini P; Santucci A
    Expert Rev Proteomics; 2009 Apr; 6(2):135-43. PubMed ID: 19385941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postgenomics of Neisseria meningitidis for vaccines development.
    Bernardini G; Braconi D; Martelli P; Santucci A
    Expert Rev Proteomics; 2007 Oct; 4(5):667-77. PubMed ID: 17941821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotechnology and vaccines: application of functional genomics to Neisseria meningitidis and other bacterial pathogens.
    Serruto D; Adu-Bobie J; Capecchi B; Rappuoli R; Pizza M; Masignani V
    J Biotechnol; 2004 Sep; 113(1-3):15-32. PubMed ID: 15380644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Living in a changing environment: insights into host adaptation in Neisseria meningitidis from comparative genomics.
    Schoen C; Joseph B; Claus H; Vogel U; Frosch M
    Int J Med Microbiol; 2007 Nov; 297(7-8):601-13. PubMed ID: 17572149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional genomics studies of the human pathogen Neisseria meningitidis.
    Del Tordello E; Serruto D
    Brief Funct Genomics; 2013 Jul; 12(4):328-40. PubMed ID: 23723380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of complete genome sequences in vaccine design.
    Saunders NJ; Butcher S
    Methods Mol Med; 2003; 87():301-12. PubMed ID: 12958464
    [No Abstract]   [Full Text] [Related]  

  • 9. Neisseria meningitidis: using genomics to understand diversity, evolution and pathogenesis.
    Caugant DA; Brynildsrud OB
    Nat Rev Microbiol; 2020 Feb; 18(2):84-96. PubMed ID: 31705134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Will Genome Analysis Elucidate Evolution, Global Transmission and Virulence of Neisseria Meningitidis Lineages?
    Golparian D; Unemo M
    EBioMedicine; 2015 Mar; 2(3):186-7. PubMed ID: 26137558
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of the immune response to Neisseria meningitidis using a proteomics approach.
    Williams JN; Christodoulides M; Heckels JE
    Methods Mol Biol; 2012; 799():343-60. PubMed ID: 21993655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal vaccines.
    Bethell D; Pollard AJ
    Expert Rev Vaccines; 2002 Jun; 1(1):75-84. PubMed ID: 12908514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microarray analyses of meningococcal genome composition and gene regulation: a review of the recent literature.
    Claus H; Vogel U; Swiderek H; Frosch M; Schoen C
    FEMS Microbiol Rev; 2007 Jan; 31(1):43-51. PubMed ID: 17096662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial genomics and pathogen evolution.
    Raskin DM; Seshadri R; Pukatzki SU; Mekalanos JJ
    Cell; 2006 Feb; 124(4):703-14. PubMed ID: 16497582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningococcal protein antigens and vaccines.
    Feavers IM; Pizza M
    Vaccine; 2009 Jun; 27 Suppl 2():B42-50. PubMed ID: 19481315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neisseria meningitidis. The pathophysiological role of lipopolysaccharides in association with meningococcal disease and septic shock].
    Pedersen MØ; Pedersen DS; Pedersen M; Penkowa M
    Ugeskr Laeger; 2008 Feb; 170(6):421-6. PubMed ID: 18252172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The analysis of Neisseria meningitidis proteomes: Reference maps and their applications.
    Bernardini G; Braconi D; Santucci A
    Proteomics; 2007 Aug; 7(16):2933-46. PubMed ID: 17628027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of virulence factors of pathogenic bacteria.
    Wu HJ; Wang AH; Jennings MP
    Curr Opin Chem Biol; 2008 Feb; 12(1):93-101. PubMed ID: 18284925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serogroup B meningococcal vaccines.
    Zimmer SM; Stephens DS
    Curr Opin Investig Drugs; 2006 Aug; 7(8):733-9. PubMed ID: 16955685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics: how it is being used to identify bacterial vaccine candidates.
    Zagursky RJ; Olmsted SB; Russell DP; Wooters JL
    Expert Rev Vaccines; 2003 Jun; 2(3):417-36. PubMed ID: 12903807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.